Ethyl pyruvate prevents lung injury through inhibition of the NF-kappa B pathway, but does not prevent bleomycin-induced lung injury

A. Mizutani, K. Sugahara, H. Yamamoto (Nishihara, Japan)

Source: Annual Congress 2010 - New insights into reactive oxygen species
Session: New insights into reactive oxygen species
Session type: E-Communication Session
Number: 3727

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Mizutani, K. Sugahara, H. Yamamoto (Nishihara, Japan). Ethyl pyruvate prevents lung injury through inhibition of the NF-kappa B pathway, but does not prevent bleomycin-induced lung injury. Eur Respir J 2010; 36: Suppl. 54, 3727

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Inhibition of neutrophil apoptosis by sphingosin-1-phopsphate through the activation of neutral sphingomyelinase in acute lung injury
Source: Annual Congress 2010 - Emerging mechanisms in lung injury
Year: 2010

PD98059 attenuates the development of bleomycin-induced lung injury and fibrosis
Source: Annual Congress 2010 - Regulation of airway pharmacology
Year: 2010

Effects of autophagy on LPS-induced lung inflammation and acute lung injury (ALI) in vitro and in vivo
Source: International Congress 2018 – Role of microbial exposure and inflammation in lung injury
Year: 2018

Dexamethasone inhibits surfactant degradation during bleomycin-induced lung injury in rats
Source: Eur Respir J 2006; 28: Suppl. 50, 855s
Year: 2006

Effect of phosphodiesterase-4 inhibitor on the inflammation, oxidative damage and apoptosis in a saline lavage-induced model of acute lung injury
Source: International Congress 2018 – Preclinical pharmacology: novel targets in airway inflammation, narrowing and neural control
Year: 2018



Activated protein C protection in endotoxin-induced lung injury is mediated by lung matrix metalloproteinases activity
Source: Annual Congress 2007 - Miscellaneous lower respiratory tract infections
Year: 2007


Dipeptide HCH6-1 inhibits neutrophil activation and protects against acute lung injury by blocking FPR1
Source: International Congress 2017 – Towards better treatments for lung disease: experimental pharmacology
Year: 2017

Kallistatin protects against LPS-induced mouse lung injury
Source: Annual Congress 2012 - The many roads to lung injury
Year: 2012


Inhaled activated protein C protects mice from ventilator-induced lung injury
Source: Annual Congress 2009 - Acute lung injury: biological mechanisms
Year: 2009


Rho-kinase inhibitor ameliorates bleomycin-induced chronic lung injury in neonatal rats
Source: Annual Congress 2011 - Issues in paediatric and neonatal intensive care
Year: 2011

Effect of curcumin on LPS-induced neutrophil activation and acute lung injury
Source: Annual Congress 2012 - Lung injury, respiratory muscles and mechanical ventilation
Year: 2012

Effects of ethyl pyruvate in a murine model of lipopolysaccharide-induced acute lung injury
Source: Eur Respir J 2005; 26: Suppl. 49, 559s
Year: 2005

Involvement of proteasome inhibition and p53 accumulation in epithelial apoptosis of lung injury
Source: Eur Respir J 2005; 26: Suppl. 49, 101s
Year: 2005

NADPH oxidase 4 deficiency protects from bleomycin-induced epithelial cell death and pulmonary fibrosis
Source: Annual Congress 2010 - New insights into reactive oxygen species
Year: 2010


NADPH oxidase 4 signaling in a ventilator-induced lung injury mice model
Source: Virtual Congress 2020 – Experimental and laboratory studies in intensive care unit medicine
Year: 2020

IL-9 protects against bleomycin-induced lethal lung injury through a prostaglandin-dependent mechanism
Source: Eur Respir J 2004; 24: Suppl. 48, 105s
Year: 2004

Inhibition of the Arp2/3 complex inhibits lung myofibroblast differentiation in vitro and attenuates bleomycin-induced pulmonary fibrosis in mice
Source: International Congress 2019 – Extracellular matrix formation and remodelling in physiology and disease
Year: 2019

The CDK4/6 inhibitor, palbociclib intensifies pulmonary inflammation in bleomycin-induced lung fibrosis
Source: Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies
Year: 2020


Lack of poly(ADP-ribose) polymerase-1 does not affect acute lung injury but induces excessive lung remodelling after hyperoxia exposure
Source: Annual Congress 2005 - Highlights of the 2005 ERS Lung Science Conference in Taormina
Year: 2005

Sirtuins inhibition modulates endotoxin-induced lung inflammation
Source: Annual Congress 2010 - Models of airways disease
Year: 2010